Karine Titier
Bordeaux, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Letter to the Editor: The Cannabinoid Consumed Is Not Necessarily the One Expected: Recent Experience with Hexahydrocannabinol.
Journal: Cannabis and cannabinoid research
Published: August 16, 2023
Methoxpropamine (MXPr) in powder, urine and hair samples: Analytical characterization and metabolite identification of a new threat.
Journal: Forensic science international
Published: December 07, 2021
Hair Analysis of Methoxphenidine in a Forensic Chemsex Case.
Journal: Journal of analytical toxicology
Published: November 17, 2020
Suitability of infrared spectroscopy for drug checking in harm reduction centres.
Journal: The International journal on drug policy
Published: June 23, 2020
Toxicological screening reveals toxic epidermal necrolysis likely carbamazepine-induced rather than idiopathic.
Journal: The journal of allergy and clinical immunology. In practice
Published: September 19, 2019
Death related to nicotine replacement therapy: A case report.
Journal: Forensic science international
Published: June 17, 2019
Biomonitoring of occupational exposure to 5-FU by assaying α-fluoro-β-alanine in urine with a highly sensitive UHPLC-MS/MS method.
Journal: The Analyst
Published: July 31, 2018
Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.
Journal: Antiviral research
Published: July 12, 2017
Trough dabrafenib plasma concentrations can predict occurrence of adverse events requiring dose reduction in metastatic melanoma.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: June 22, 2017
High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MS.
Journal: Journal of pharmaceutical and biomedical analysis
Published: June 08, 2017
An UPLC-MS/MS method for the quantification of BRAF inhibitors (vemurafenib, dabrafenib) and MEK inhibitors (cobimetinib, trametinib, binimetinib) in human plasma. Application to treated melanoma patients.
Journal: Clinica chimica acta; international journal of clinical chemistry
Published: December 22, 2016
Last Updated: 09/26/2026